1. Market Research
  2. > Consumer Electronics
  3. > Portable Devices Market Trends
  4. > The Sunshine Act: Impact on US Physician Behavior

The Sunshine Act: Impact on US Physician Behavior

  • August 2014
  • -
  • Industry Standard Research
  • -
  • 201 pages

The Sunshine Act has been finalized. The data have been (and are being) collected. The figures are being tallied. The key question for pharma is, and may be for some time, “How significant is this impact?”

In this report, ISR asks physicians across five specialties (Cardiology, CNS / Neurology, Oncology, Primary Care, Respiratory / Pulmonology) to assess the impact that the Sunshine Act has had on their practice now that it has been implemented. Building on data collected two years ago in ISR’s The Sunshine Act: Pharma Impact – Changes in US Physician Behavior, this new edition explores physicians’ evolving concerns with the Sunshine Act.

Report Overview

The Sunshine Act has been finalized. The data have been (and are being) collected. The figures are being tallied. The key question for pharma is, and may be for some time, “How significant is this impact?” In this report, ISR asks physicians across five specialties (Cardiology, CNS / Neurology, Oncology, Primary Care, Respiratory / Pulmonology) to assess the impact that the Sunshine Act has had on their practice now that it has been implemented. Building on data collected two years ago in ISR’s The Sunshine Act: Pharma Impact – Changes in US Physician Behavior, this new edition explores physicians’ evolving concerns with the Sunshine Act.

What you will learn in this report:

• How participation in various interactions with pharma has changed since implementation of the Sunshine Act
• Rationale for why the Sunshine Act is negatively impacting some practices
• The most valuable and effective channels of information
• Preferred delivery methods for different types of information
• Which pharmaceutical companies have the most effective sales teams and which have the best online / e-Detailing presentations

Table Of Contents

The Sunshine Act: Impact on US Physician Behavior
Table of Contents

Copyright and Usage Guidelines ..9
Introduction ...10
Methodology .12
Definition of the Sunshine Act ...13
Physician Demographics and Qualifications ..14
Average Years in Practice Post-Residency .14
Average Number of Patient Visits per Week .14
Executive Summary 15
Change in Interactions with Pharma .16
Rationale for Negative Impact on Practice ...19
Physician Relationships with Sales Reps ...20
Specialty Profiles 22
Cardiology ..23
CNS / Neurology 24
Oncology 25
Primary Care ..26
Respiratory / Pulmonology 27
Cardiology ..28
Practice Dynamics .29
Understanding of Sunshine Act .29
Expecting Notice of Benefit Value .29
Practice Preparedness for Sunshine Act ...30
Favorability toward Public Database of Relationships ..30
Implementation of Training on Sunshine Act 31
Sunshine Act Training Entities Used ..31
Likelihood of Implementing Training on Sunshine Act ..32
Most Preferred Sunshine Act Training Entities .32
Impact of Sunshine Act on Practice ..33
Rationale for Negative Impact on Practice ...34
Venues for Completing CMEs 35
Decision-Makers for Sales Rep Visitation ...35
Frequency of Representative Interaction ..36
Restrictions on Representative Visits .36
Value: Information Channels ..37
Most Valuable Information Channels for Medications/Treatments ...37
Most Effective Information Channels .38
Most Valuable Discussion Topics 39
Preferred Delivery Method for Information ...40
Sales Representative Trust .41
Pharma Company with Most Effective Team .42
Pharma Companies with Best Online Presentations, e-Detailing, and Webinars ..43
Tablet or iPad Use during Details ...44
Perceived Value of Tablet/iPad ...44
Frequency of Interaction: Information Channels ...45
Frequency of Interactions with Pharmaceutical Industry ...45
Frequency of Interactions with Pharmaceutical Industry: Days per Year ...46
Information Channels with Increased Utilization in Next 12 Months .47
Information Channels with Decreased Utilization in Next 12 Months 48
Interaction Change Since Sunshine Act Implementation 49
Respondent Demographics and Qualifications ...50
Office Type ..50
Specialty Certified ...50
Years in Practice ..51
Number of Patients per Week 51
Office Location 52
Practice Setting 52
Number of Physicians at Practice 53
Number of PAs and NPs at Practice 53
Age ...54
CNS/Neurology ..55
Practice Dynamics .56
Understanding of Sunshine Act .56
Expecting Notice of Benefit Value .56
Practice Preparedness for Sunshine Act 57
Favorability toward Public Database of Relationships ...57
Implementation of Training on Sunshine Act 58
Sunshine Act Training Entities Used ..58
Likelihood of Implementing Training on Sunshine Act ..59
Most Preferred Sunshine Act Training Entities .59
Impact of Sunshine Act on Practice ..60
Rationale for Negative Impact on Practice ...61
Rationale for Positive Impact on Practice .61
Venues for Completing CMEs ...62
Decision-Makers for Sales Rep Visitation ..62
Frequency of Representative Interactions 63
Restrictions on Representative Visits 63
Value: Information Channels .64
Most Valuable Information Channels for Medications/Treatments ..64
Most Effective Information Channels 65
Most Valuable Discussion Topics ...66
Preferred Delivery Method for Information ..67
Sales Representative Trust 68
Pharma Company with Most Effective Team .69
Pharma Companies with Best Online Presentations, e-Detailing, and Webinars ..70
Tablet or iPad Use during Details ...71
Perceived Value of Tablet/iPad ..71
Frequency of Interaction: Information Channels ...72
Frequency of Interactions with Pharmaceutical Industry ..72
Frequency of Interactions with Pharmaceutical Industry: Days per Year ..73
Information Channels with Increased Utilization in Next 12 Months 74
Information Channels with Decreased Utilization in Next 12 Months ...75
Interaction Change Since Sunshine Act Implementation ...76
Respondent Demographics and Qualifications ..77
Office Type ..77
Specialty Certified ...77
Years in Practice ..78
Number of Patients per Week 78
Office Location ...79
Practice Setting ..79
Numbers of Physicians at Practice .80
Number of PAs and NPs at Practice ...80
Age ..81
Oncology 82
Practice Dynamics ..83
Understanding of Sunshine Act ..83
Expecting Notice of Benefit Value ..83
Practice Preparedness for Sunshine Act 84
Favorability toward Public Database of Relationships ...84
Implementation of Training on Sunshine Act .85
Sunshine Act Training Entities Used ...85
Likelihood of Implementing Training on Sunshine Act ...86
Most Preferred Sunshine Act Training Entities ..86
Impact of Sunshine Act on Practice ...87
Rationale for Negative Impact on Practice .88
Rationale for Positive Impact on Practice ...88
Venues for Completing CMEs .89
Decision-Makers for Sales Rep Visitation ...89
Frequency of Representative Interaction ...90
Restrictions on Representative Visits .90
Value: Information Channels ..91
Most Valuable Information Channels for Medications/Treatments ...91
Most Effective Information Channels .92
Most Valuable Discussion Topics 93
Preferred Delivery Method for Information ...94
Sales Representative Trust .95
Pharma Company with Most Effective Team .96
Pharma Companies with Best Online Presentations, e-Detailing, and Webinars ..97
Tablet or iPad Use during Details ...98
Perceived Value of Tablet/iPad ..98
Frequency of Interaction: Information Channels ...99
Frequency of Interactions with Pharmaceutical Industry ..99
Frequency of Interactions with Pharmaceutical Industry: Days per Year 100
Information Channels with Increased Utilization in Next 12 Months ..101
Information Channels with Decreased Utilization in Next 12 Months .102
Interaction Change Since Sunshine Act Implementation .103
Respondent Demographics and Qualifications 104
Office Type ...104
Specialty Certified 104
Years in Practice ...105
Number of Patients per Week .105
Office Location .106
Practice Setting 106
Number of Physicians at Practice 107
Number of PAs and NPs at Practice .107
Age ...108
Primary Care 109
Practice Dynamics 110
Understanding of Sunshine Act 110
Expecting Notice of Benefit Value 110
Practice Preparedness for Sunshine Act ..111
Favorability toward Public Database of Relationships .111
Implementation of Training on Sunshine Act ...112
Sunshine Act Training Entities Used .112
Likelihood of Implementing Training on Sunshine Act .113
Most Preferred Sunshine Act Training Entities .113
Impact of Sunshine Act on Practice .114
Rationale for Negative Impact on Practice ..115
Rationale for Positive Impact on Practice 115
Venues for Completing CMEs ..116
Decision-Makers for Sales Rep Visitation .116
Frequency of Representative Interaction 117
Restrictions on Representative Visits ...117
Value: Information Channels 118
Most Valuable Information Channels for Medications/Treatments 118
Most Effective Information Channels ...119
Most Valuable Discussion Topics ..120
Preferred Delivery Method for Information .121
Sales Representative Trust 122
Pharma Company with Most Effective Team 123
Pharma Companies with Best Online Presentations, e-Detailing, and Webinars ……………………...124
Tablet or iPad Use during Details .125
Perceived Value of Tablet/iPad 125
Frequency of Interaction: Information Channels .126
Frequency of Interactions with Pharmaceutical Industry 126
Frequency of Interactions with Pharmaceutical Industry: Days per Year 127
Information Channels with Increased Utilization in Next 12 Months ..128
Information Channels with Decreased Utilization in Next 12 Months .129
Interaction Change Since Sunshine Act Implementation .130
Respondent Demographics and Qualifications .131
Office Type 131
Specialty Certified .131
Years in Practice 132
Number of Patients per Week ..132
Office Location ..133
Practice Setting .133
Physicians at Practice 134
Number of PAs and NPs at Practice ..134
Age ...135
Respiratory/ Pulmonology ...136
Practice Dynamics 137
Understanding of Sunshine Act 137
Expecting Notice of Benefit Value 137
Practice Preparedness for Sunshine Act ..138
Favorability toward Public Database of Relationships .138
Implementation of Training on Sunshine Act ..139
Sunshine Act Training Entities Used 139
Likelihood of Implementing Training on Sunshine Act 140
Most Preferred Sunshine Act Training Entities 140
Impact of Sunshine Act on Practice .141
Rationale for Negative Impact on Practice ..142
Rationale for Positive Impact on Practice ...142
Venues for Completing CMEs ..143
Decision-Makers for Sales Rep Visitation 143
Frequency of Representative Interactions ..144
Restrictions on Representative Visits ..144
Value: Information Channels ...145
Most Valuable Information Channels for Medications/Treatments ...145
Most Effective Information Channels ..146
Most Valuable Discussion Topics .147
Preferred Delivery Method for Information 148
Sales Representative Trust ...149
Pharma Company with Most Effective Team ...150
Pharma Companies with Best Online Presentations, e-Detailing, and Webinars ………………………...151
Tablet or iPad Use during Details .152
Perceived Value of Tablet/iPad 152
Frequency of Interaction: Information Channels .153
Frequency of Interactions with Pharmaceutical Industry 153
Frequency of Interactions with Pharmaceutical Industry: Days per Year 154
Information Channels with Increased Utilization in Next 12 Months ..155
Information Channels with Decreased Utilization in Next 12 Months .156
Interaction Change Since Sunshine Act Implementation .157
Respondent Demographics and Qualifications 158
Office Type ...158
Specialty Certified 158
Years in Practice ...159
Number of Patients per Week .159
Office Location .160
Practice Setting 160
Number of Physicians at Practice .161
Number of PAs and NPs at Practice .161
Age ...162
Across Therapeutic Areas 163
Understanding of Sunshine Act ...164
Expecting Notice of Benefit Value ...165
Practice Preparedness for Sunshine Act ..166
Favorability toward Public Database of Relationships .167
Implementation of Training on Sunshine Act ..168
Sunshine Act Training Entities Used 169
Likelihood of Implementing Training on Sunshine Act 170
Most Preferred Sunshine Act Training Entities 171
Impact of Sunshine Act on Practice .172
Rationale for Negative Impact on Practice .173
Rationale for Positive Impact on Practice ...175
Venues for Completing CMEs .176
Decision-Makers for Sales Rep Visitation 177
Frequency of Representative Interactions ..178
Restrictions on Representative Visits ..179
Value: Information Channels ...180
Most Valuable Information Channels for Medications/Treatments ...180
Most Effective Information Channels .181
Most Valuable Discussion Topics 182
Preferred Delivery Method for Information ...183
Sales Representative Trust ...184
Pharma Company with Most Effective Team ...185
Pharma Companies with Best Online Presentations, e-Detailing, and Webinars ………………………...186
Tablet or iPad Use during Details .187
Average Tablet or iPad Use during Details ...187
Perceived Value of Tablet/iPad 188
Frequency of Interaction: Information Channels .189
Frequency of Interactions with Pharmaceutical Industry 189
Frequency of Interactions with Pharmaceutical Industry: Days per Year 190
Frequency of Interactions with Pharmaceutical Industry: Days per Year, continued …………………...191
Information Channels with Increased Utilization in Next 12 Months ..192
Information Channels with Decreased Utilization in Next 12 Months .193
Interaction Change Since Sunshine Act Implementation .194
Respondent Demographics and Qualifications 195
Office Type ...195
Specialty Certified ...195
Therapeutic Specialty ..196
Years in Practice ..196
Number of Patients per Week .197
Office Location .198
Practice Setting 199
Number of Physicians at Practice 199
Number of PAs and NPs at Practice .200
Age ...200
About Industry Standard Research ..201

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Navigational Equipment Markets in the World to 2020 - Market Size, Development, and Forecasts

Navigational Equipment Markets in the World to 2020 - Market Size, Development, and Forecasts

  • $ 21799
  • Industry report
  • November 2016
  • by Global Research & Data Services

The expansion of the global navigational equipment industry is forecast to reach 0.9% p.a. in the coming years. Between 2009 and 2015 the market increased with an average annual growth of 3.2%. Currently, ...

Global Mobile Devices Market Analytics to 2020: Mobile Handset Sales by Category, Type of Customer, Price, Vendor, Features, Smartphones, OS, Technology and Generation

Global Mobile Devices Market Analytics to 2020: Mobile Handset Sales by Category, Type of Customer, Price, Vendor, Features, Smartphones, OS, Technology and Generation

  • $ 14995
  • Industry report
  • September 2016
  • by Pyramid Research

Summary Pyramid Research report "Global Mobile Devices Market Analytics to 2020: Mobile Handset Sales by Category, Type of Customer, Price, Vendor, Features, Smartphones, OS, Technology and Generation" ...

Europe Mobile Devices Market Analytics to 2020: Mobile Handset Sales by Category, Type of Customer, Price, Vendor, Features, Smartphones, OS, Technology and Generation

Europe Mobile Devices Market Analytics to 2020: Mobile Handset Sales by Category, Type of Customer, Price, Vendor, Features, Smartphones, OS, Technology and Generation

  • $ 10995
  • Industry report
  • September 2016
  • by Pyramid Research

Summary Pyramid Research report "Europe Mobile Devices Market Analytics to 2020: Mobile Handset Sales by Category, Type of Customer, Price, Vendor, Features, Smartphones, OS, Technology and Generation" ...

E-retail In The Uk 2016

July 2016 $ 8600

ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.